DNASE1L3 and hepatocellular carcinoma: Studies have shown that the infusion of NET-degrading enzymes (DNase I) combined with NK cells into postoperative hepatocellular carcinoma (HCC) patients significantly reduces the risk of recurrence after HCC resection, with no notable systemic toxicity observed (82).